Literature DB >> 1505572

Hypergalactosaemia and portosystemic encephalopathy due to persistence of ductus venosus Arantii.

R Gitzelmann1, U V Arbenz, U V Willi.   

Abstract

Hypergalactosaemia was discovered in a newborn girl during routine metabolic screening. Hereditary enzyme deficiency was ruled out. Because hypergalactosaemia persisted, an open ductus venosus Arantii was suspected but remained undetected by conventional two-dimensional ultrasonography. It was demonstrated by combined colour and pulsed wave Doppler sonography. At age 3 years 6 months, the girl developed initial symptoms of portosystemic encephalopathy which progressed and was treated by protein restriction, oral lactulose and flumazenil, with some success. In the absence of enzyme deficiency, hypergalactosaemia in the newborn is an early sign of duct persistence. For the unambiguous diagnosis of an open duct, colour Doppler sonography is the method of choice. Pulsed wave Doppler sonography is recommended for pathophysiological characterisation of the splanchnic venous return.

Entities:  

Mesh:

Year:  1992        PMID: 1505572     DOI: 10.1007/bf01957721

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  PORTAL-SYSTEMIC ENCEPHALOPATHY DUE TO CONGENITAL INTRAHEPATIC SHUNTS.

Authors:  N H RASKIN; J B PRICE; R A FISHMAN
Journal:  N Engl J Med       Date:  1964-01-30       Impact factor: 91.245

2.  Studies on portal hypertension. IV. The clinical and physiopathologic significance of self-established (nonsurgical) portal systemic venous shunts.

Authors:  L M ROUSSELOT; A H MORENO; W F PANKE
Journal:  Ann Surg       Date:  1959-09       Impact factor: 12.969

3.  Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Authors:  A S Basile; R D Hughes; P M Harrison; Y Murata; L Pannell; E A Jones; R Williams; P Skolnick
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

4.  Enormous intrahepatic communication between the portal vein and the hepatic vein.

Authors:  K Ohtomo; S Furui; M Saito; T Kokubo; Y Itai; M Iio
Journal:  Clin Radiol       Date:  1986-09       Impact factor: 2.350

5.  Anomalous venous connections involving the portal system.

Authors:  W Reichardt; G H Bützow; W Erbe
Journal:  Cardiovasc Radiol       Date:  1979

6.  Intrahepatic portal-systemic shunt: its etiology and diagnosis.

Authors:  Y Horiguchi; T Kitano; H Imai; M Ohsuki; M Yamauchi; M Itoh
Journal:  Gastroenterol Jpn       Date:  1987-08

7.  Spontaneous portal-hepatic venous shunt via an intrahepatic portal vein aneurysm.

Authors:  K Takayasu; N Moriyama; Y Shima; Y Muramatsu; H Goto; T Yamada; M Makuuchi; S Yamasaki; N Okazaki
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682

8.  Uridine diphosphate galactose 4'-epimerase deficiency. IV. Report of eight cases in three families.

Authors:  R Gitzelmann; B Steinmann; B Mitchell; E Haigis
Journal:  Helv Paediatr Acta       Date:  1977-04

9.  Portal-systemic encephalopathy due to a congenital portocaval shunt.

Authors:  R K Kerlan; R D Sollenberger; A J Palubinskas; N H Raskin; P W Callen; W K Ehrenfeld
Journal:  AJR Am J Roentgenol       Date:  1982-11       Impact factor: 3.959

10.  Hepatoencephalopathy associated with situs inversus of abdominal organs and vascular anomalies in a dog.

Authors:  C L Lohse; R R Selcer; P F Suter
Journal:  J Am Vet Med Assoc       Date:  1976-04-15       Impact factor: 1.936

View more
  15 in total

1.  Congenital porto-left renal venous shunt as a cause of galactosaemia.

Authors:  N Mizoguchi; N Sakura; H Ono; K Naito; M Hamakawa
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Time of closure of ductus venosus in term and preterm neonates.

Authors:  M Kondo; S Itoh; T Kunikata; T Kusaka; T Ozaki; K Isobe; S Onishi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

3.  Patency of the ductus venosus and disease.

Authors:  F H Adams
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

4.  Significant correlations between the flow volume of patent ductus venosus and early neonatal liver function: possible involvement of patent ductus venosus in postnatal liver function.

Authors:  K Murayama; H Nagasaka; K Tate; Y Ohsone; M Kanazawa; K Kobayashi; Y Kohno; M Takayanagi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01-31       Impact factor: 5.747

5.  Successful transcatheter closure of a large patent ductus venosus with the Amplatzer vascular plug II.

Authors:  Y K Cho; N-K Chang; J S Ma
Journal:  Pediatr Cardiol       Date:  2009-03-18       Impact factor: 1.655

6.  Outcome of intrahepatic portosystemic shunt diagnosed prenatally.

Authors:  Bérengère Francois; Fréderic Gottrand; Alain Lachaux; Corinne Boyer; Bernard Benoit; Stéphanie De Smet
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

Review 7.  The control of the ductus venosus: an update.

Authors:  F Coceani
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

8.  Differential diagnosis of neonatal mild hypergalactosaemia detected by mass screening: clinical significance of portal vein imaging.

Authors:  Y Nishimura; G Tajima; A Dwi Bahagia; A Sakamoto; H Ono; N Sakura; K Naito; M Hamakawa; C Yoshii; M Kubota; K Kobayashi; T Saheki
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Patent ductus venosus associated with a hyperintense globus pallidum on T1-weighted magnetic resonance imaging and pulmonary hypertension.

Authors:  S Yanai; T Minami; K Sonoda; K Gondo; K Tasaki; T Hijii; J Fukushige; K Ueda; T Hirata; T Hayashi
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

10.  Remittent hyperammonemia in congenital portosystemic shunt.

Authors:  Giovanni Battista Ferrero; Francesco Porta; Elisa Biamino; Alessandro Mussa; Emanuela Garelli; Francesca Chiappe; Andrea Veltri; Margherita Cirillo Silengo; Fabrizio Gennari
Journal:  Eur J Pediatr       Date:  2009-07-18       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.